Trial Profile
A Phase III Randomized Multicenter Study,Comparing an Induction Chemotherapy Followed by Irradiation and Concurrent Erbitux Versus Chemoradiotherapy for Patients With Locoregional Advanced Head and Neck Cancers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Docetaxel (Primary) ; Carboplatin; Cisplatin; Fluorouracil
- Indications Head and neck cancer
- Focus Therapeutic Use
- 17 Jan 2019 Status changed from active, no longer recruiting to completed.
- 17 Jul 2018 Results published in the Journal of Clinical Oncology
- 25 Oct 2017 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2018.